资源描述：
《脉络宁治疗高血压脑出血90例疗效观察.doc》由会员上传分享，免费在线阅读，更多相关内容在工程资料-天天文库。
1、脉络宁治疗高血压脑出血90例疗效观察doi：10.3969/j.issn.1007-614x.2014.15.61摘耍冃的：探讨脉络宁治疗高血压脑出血的临床疗效。方法：2012年12月-2013年12月收治高血压脑出血患者180例，随机分成对照组和观察组各90例。对照组治疗方法：急性期给予胞二磷胆碱0.75mg+0.9%氯化钠注射液250ml,20%甘露醇静滴治疗。观察组在対照组治疗第5天基础上加用脉络宁20ml+0.9%氯化钠注射液250ml静滴治疗，连续治疗3周。结果：观察组治疗前血肿量(18.66±4.32)ml,治
2、疗后血肿量(3.74±0.77)ml；对照组治疗前血肿量(18.63±4.33)ml,治疗后血肿量(6.66±0.88)mlo观察组治疗后与对照组治疗后比较差异有统计学意义(P<0.05)o观察组治疗前神经功能评分(24.7±9・9)分，治疗后神经功能评分(10.4±7.5)分；对照组治疗前神经功能评分(23・9±9.7)分，治疗后神经功能评分(19・7±9・1)分。治疗后两组比较差异有统计学意义(P〈0.05)。结论：脉络宁可以冇效减少血肿量，冇效改善神经功能，是治疗高血压脑出血的有效药物。关键词脉络宁高血压性脑出血神经
3、功能评分Curativeeffectobservationof90casesofhypertensivecerebralhemorrhagetreatedwithMaiLuoNingMaZhenxiuTheCommunityHealthCentreofShenlu,MachiTown,JiuyuanDistrict,BaotouCity,InnerMongolia014010AbstractObjective:Toexplorethecurativeeffectofhypertensivecerebralhemorrhag
4、etreatedwithMaiLuoNing・Methods：180patientswithhypertensivecerebralhemorrhagewereselectedfromDecember2012toDecember2013・Theywererandomlydividedintothecontrolgroupandtheobservationgroupwith90casesineach.Thecontrolgroupwastreatedbyciticoline0.75mg+250mlNS,20%mannitol
5、forintravenousdripatacuteperiod・TheobservationgroupaddedMaiLuoNing20ml+250mlNSforintravenousdriponthebasisoffivedaystreatmentofcontrolgroup,continuoustreatmentfor3weeks・Results：Intheobservationgroup,thehematomavolumebeforetreatmentwas18.66±4.32ml,andthehematomavol
6、umeaftertreatmentwas3.74±0.77m1.Inthecontrolgroup,thehematomavolumebeforetreatmentwas18.63+4.33ml,andthehematomavolumeaftertreatmentwas6.66±0.88m1.Therewassignificantdifferenceaftertreatmentofthetwogroups(P<0e05).Intheobservationgroup,theneurologicalfunctionscoreb
7、eforetreatmentwas24.7±9.9,andtheneurologicalfunctionscoreaftertreatmentwas10.4±7・5.Inthecontrolgroup,theneurologicalfunctionscorebeforetreatmentwas23・9±9.7,andtheneurologicalfunctionscoreaftertreatmentwas19.7±9・1.Therewassignificantdifferenceaftertreatmentofthetwo
8、groups(P〈0.05).Conclusion：MaiLuoNingcaneffectivelyreducethevolumeofhematoma,andimprovenervefunction.Itisaneffectivedrugfortreatmentofhypertensivecerebra
